Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years

SUMMARY: Bone mineral density response to once weekly delayed-release formulation of risedronate, given before or following breakfast, was non-inferior to that seen with traditional immediate-release risedronate given daily before breakfast. Delayed-release risedronate is a convenient dosing regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: McClung, M. R., Balske, A., Burgio, D. E., Wenderoth, D., Recker, R. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536960/
https://www.ncbi.nlm.nih.gov/pubmed/23079690
http://dx.doi.org/10.1007/s00198-012-2175-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536960/
https://www.ncbi.nlm.nih.gov/pubmed/23079690
http://dx.doi.org/10.1007/s00198-012-2175-7

Ejemplares similares